RSS-Feed abonnieren
DOI: 10.1055/s-2002-19964
© Georg Thieme Verlag Stuttgart · New York
A Blood Pressure Cut-Off Level Identified for Renal Failure, but not for Macrovascular Complications in Type 2 Diabetes: A 10-year Observation Study
Publikationsverlauf
23 January 2001
2 August 2001
Publikationsdatum:
14. August 2002 (online)

Abstract
Aims: Can a cut-off blood pressure level for major complications be identified?
Methods: A 10 years observation study in 385 type 2 diabetic patients.
Results: 158 patients were affected with myocardial infarction, stroke, renal failure or death, which occurred in 68, 55, 19 and 109 patients, respectively. No patient with a blood pressure below 140 mmHg and/or a diastolic blood pressure below 75 mmHg developed uraemia during the observation period. No such cut-off level was seen for myocardial infarction, stroke or death.
Conclusions: This study shows that there seems to be a cut-off level for blood pressure for development of renal failure, while no level was found for cardio- or cerebrovascular disorders.
Key words
Blood Pressure - Mortality - Renal Failure - Myocardial Infarction - Stroke
References
- 1 UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998 317: 703-713
- 2 Agardh C-D, Agardh E, Torffvit O. The prognostic value of albuminuria for the development of cardiovascular disease and retinopathy: a 5-year follow-up study of 451 patients with type 2 diabetes mellitus. Diab Res Clin Pract. 1996; 32 35-44
- 3 Sasaki A, Horiuchi N, Hasagawa K, Uehara M. Persistent albuminuria as an index of diabetic nephropathy in type 2 diabetic patients in Osaka, Japan - incidence, risk factors, prognosis and causes of death. Diab Res Clin Pract. 1989; 7 299-306
- 4 MacLeod J M, Lutale J, Marshall S M. Albumin excretion and vascular death in NIDDM. Diabetologia. 1995; 38 610-616
- 5 Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H. et al . Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996; 39 1577-1583
- 6 Walters D P, Gatling W, Houston A C, Mullee M A, Julious S A, Hill R D. Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabetic Med. 1994; 11 968-973
- 7 Niskanen L K, Parviainen M, Penttilä I, Uusitupa M IJ. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care. 1996; 19 486-493
- 8 Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hörmann A, Holle R. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich general practitioner project. Diabetologia. 1996; 39 1540-1545
- 9 Damsgaard E M, Frøland A, Jørgensen O D, Mogensen C E. Eight to nine year mortality on known non-insulin dependent diabetics and controls. Kidney Int. 1992; 41 731-735
- 10 Hasslacher C, Bostedt-Kiesel A, Kempe H P, Wahl P. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993; 36 1051-1056
O. Torffvit, M.D., Ph.D.
Department of Medicine · University Hospital
221 85 Lund · Sweden
Telefon: + 46 (46) 2220702
Fax: + 46 (46) 2110908
eMail: Ole.Torffvit@med.lu.se